Clemex creates "Clemex Europe"
August 12 2012 - 8:35AM
PR Newswire (Canada)
New subsidiary should enable the Company to speed-up growth in
European markets Symbol: CXG.A-TSX-V www.clemex.com Shares
Outstanding : 29,699,810 MONTREAL, Aug. 14, 2012 /CNW Telbec/ -
Clemex Technologies Inc. is pleased to announce the opening of its
subsidiary "Clemex Europe" in France. This new subsidiary will be
owned jointly by Clemex Technologies Inc. (75%) and RAL Diagnostics
(25%). It will be located in Martillac (Bordeaux) and operated from
the office premises of RAL Diagnostics. This expansion in Europe is
in accordance with both Clemex and RAL Diagnostics strategic
development plans outlined after their partnership agreement was
signed last year. For several years, the Company had hoped to
expand in Europe to further develop growth on that market. The
expansion of operations had become essential with the new medical
instruments designed for the biomedical field. When asked to
comment, president and CEO, Mr. Clement Forget stated "We are very
pleased to finally have permanent physical presence in France. The
European market has excellent commercial development potential for
all products designed by Clemex. There is a very important European
clientele which have to same needs and demands as our North
American clients. However, we have never been able to serve the
demands on this market as well as we could with no qualified sales
representatives physically present in Europe. Along with our new
partner, RAL Diagnostics, we have set the grounds necessary to
expand with confidence, hence, obtain business development on this
market which should meet our goals." Mr. Frédéric Imbs, president
and general manager of RAL Diagnostic has declared on his part "The
opportunity to have the Clemex products and Clemex expertise will
be greatly helpful for us in continuing our joint effort to,
design, build, manufacture, and sell our products destined to the
biomedical market. Combining our efforts and strengths, we have
concluded a win-win arrangement, that can only be mutually
beneficial to both companies." About RAL Diagnostics RAL
Diagnostics is a manufacturer of biological stains intended for the
field of human and animal health, scientific research, medical
diagnosis, and industry. These stains are available in liquids or
ready to use kits. RAL Diagnostics serves 6,000 medical analysis
laboratories and anatomopathology laboratories of France thanks to
a network of 35 distributors and 180 representatives. The company
is present in more than 40 countries in the world. About Clemex
Technologies, Inc. Clemex Technologies Inc. develops, manufactures
and markets image analysis systems and software used by quality
control and research microscopy laboratories. Clemex customer
base spans over many countries in America, Europe, Asia and
encompasses major Research and Development Centers, prestigious
Universities and large manufacturing industries in various fields
including healthcare, automotive, aerospace, raw materials
manufacturing, pharmaceuticals, mining and other sectors. The TSX
Venture Exchange has not reviewed and does not accept
responsibility for the adequacy and accuracy of this news release.
CLEMEX TECHNOLOGIES INC. CONTACT: CLEMEX TECHNOLOGIES INC, 800
Guimond,Longueuil, QC, Canada J4G 1T5,Contact:Clement ForgetTel:
450.651.6573Email: ir@clemex.com
Copyright
Clemex Technologies Inc. (TSXV:CXG.A)
Historical Stock Chart
From Jun 2024 to Jul 2024
Clemex Technologies Inc. (TSXV:CXG.A)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about (TSX Venture Exchange): 0 recent articles
More Clemex Technologies Inc. News Articles